Fri, Dec 26, 2014, 8:30 AM EST - U.S. Markets open in 1 hr.

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrt13 chrt13 Mar 13, 2008 2:10 AM Flag

    How my 100K investment in Pfizer is faring

     

    12/01 - 180,300 ($27.86)
    12/04 - 098,985 ($24.90) Torcetrapib failure
    12/29 - 128,925 ($25.90) Year-end 2006 close
    06/01 - 196,065 ($27.68) Closing high for 2007
    07/17 - 152,000 ($25.96) Session prior to Q2-07 earnings
    07/31 - 064,285 ($23.51) Interim low valuation
    10/05 - 138,925 ($25.58) Last major high of 2007
    10/31 - 102,250 ($24.61) Just before credit crunch fears
    11/26 - 027,895 ($22.30) Closing low for 2007
    12/07 - 091,635 ($24.40) Interim high
    12/31 - 037,845 ($22.73) Year-end 2007 close
    01/03 - 051,680 ($23.18)
    01/04 - 038,340 ($22.83)
    01/08 - 060,690 ($23.47) S & P loses 5.3% first week in Jan.
    01/10 - 079,945 ($24.08)
    01/22 - 014,175 ($22.23) S & P loses 10.7% YTD
    01/23 - 034,985 ($22.86) Q4-07 earnings, key reversal day
    01/24 - 040,615 ($23.05)
    01/25 - 024,160 ($22.61)
    02/01 - 057,110 ($23.59) S & P gains 5.3% from 1/22 low
    02/04 - 059,220 ($23.63)
    02/05 - 037,965 ($22.96) 370-point Dow loss
    02/06 - 035,210 ($22.59) XD 32 cts, 3-day S & P loss of 4.9%
    02/11 - 021,605 ($22.20)
    02/13 - 036,440 ($22.74)
    02/15 - 023,180 ($22.33)
    02/26 - 039,980 ($22.83)
    02/29 - 021,820 ($22.28) 316-point Dow loss
    03/10 -(014,525)($21.15) S & P loses 7.8% since 2/27, 2008 low
    03/11 - 001,590 ($21.72) Dow gains 417 points
    03/12 -($13,475)($21.28)


    Since year-end 2006, the investment is down by 110.5% ($142,400) on a 12.2% decrease in the stock price including four 29-cent quarterly dividend payments and one 32-cent payment. Excluding dividends, the stock is down by 17.8% since then.

    From 11/17/04 inception, the investment is down by 32.7% annualized with the S & P 500 compounded annualized return being a positive 3.2%.

    This investment is highly-leveraged to the point where I earn about six times what a buy-and-hold investor does up to $27.50. However, I still earn a decent return if the stock does nothing at all (20 to 25% earned per year).

    My current breakeven is now $24.45 at June options expiration. Every point between $22.50 and $25.00 means about 41K over time. Between $25.01 and $27.50, every point means about 39K.
    Every point below $22.50 means about 28K.

    With the stock at the same closing price as it is now ($21.28) at June options expiration, the investment would be valued at negative 14K.

    If Pfizer is $25.00 at June expiration, I will be
    able to cash out for 123K factoring in the effects of remaining rollovers.

    If Pfizer is $27.50 at June expiration, I will be able to cash out for 220K.

    If Pfizer is $31 in mid-January 2009, I will be able to cash out for at least 340K

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PFE
31.42-0.03(-0.10%)Dec 24 1:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
GoPro, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Amira Nature Foods Ltd.
NYSEWed, Dec 24, 2014 1:04 PM EST